By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
This JAMA article should get the attention of internists and the ACP who fail to recognize the importance of T2T and SUA monitoring. ACR and EULAR advocate monitoring SUA in everyone on ULT or problematic gout (of course pledging to a T2T strategY).. This CV and scary MACE risk should be easily endorsing for us rheumatologists.